Markets:

Overview

News

Currencies

International

Treasuries

Arcutis Biotherapeutics, Inc. - Common stock (NQ:ARQT)

26.09 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arcutis Biotherapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 Next >

3 Biotech Stocks With Key Catalysts Coming in December ↗

November 15, 2023

Some of the most exciting opportunities can be found in biotech stocks, especially if there's a powerful catalyst just around the corner.

Via InvestorPlace

What 8 Analyst Ratings Have To Say About Arcutis Biotherapeutics ↗

November 06, 2023

Via Benzinga

DraftKings To Rally Over 48%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 06, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 03, 2023

Via Benzinga

Top 5 Health Care Stocks That Are Preparing To Pump In November ↗

November 03, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Earnings Outlook For Arcutis Biotherapeutics ↗

November 02, 2023

Via Benzinga

Analyst Expectations for Arcutis Biotherapeutics's Future ↗

October 13, 2023

Via Benzinga

Where Arcutis Biotherapeutics Stands With Analysts ↗

September 25, 2023

Via Benzinga

Earnings Scheduled For November 3, 2023 ↗

November 03, 2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

Via Benzinga

MSP Recovery And 3 Other Stocks Under $3 Insiders Are Buying ↗

October 27, 2023

The Dow Jones closed lower by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Why Shares of Arcutis Biotherapeutics Fell This Week ↗

September 07, 2023

The company released phase 3 trial results for an atopic dermatitis cream.

Via The Motley Fool

7 Analysts Have This to Say About Arcutis Biotherapeutics ↗

August 10, 2023

Via Benzinga

Nasdaq Down Over 1%; Autoliv Raises FY23 Sales Outlook ↗

October 20, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Friday. The Dow traded down 0.61% to 33,209.97 while the NASDAQ fell 1.24% to 13,022.16. The S&P...

Via Benzinga

Topics Stocks

Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 20, 2023

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.

Via Benzinga

Gold Rises Over 1%; Schlumberger Shares Fall After Q3 Results ↗

October 20, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.31% to 33,309.28 while the NASDAQ fell 1.09% to 13,042.83. The S&P 500 also...

Via Benzinga

Topics Stocks

8 Analysts Have This to Say About Arcutis Biotherapeutics ↗

July 18, 2023

Via Benzinga

Analyst Ratings for Arcutis Biotherapeutics ↗

June 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 20, 2023

Via Benzinga

Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

October 20, 2023

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares surged 95.5% to $0.6226 in pre-market trading after jumping 34% on Thursday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 20, 2023

We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching on Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 19, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023 ↗

October 13, 2023

Via Benzinga

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday ↗

September 26, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Arcutis Biotherapeutics Reveals Promising Data From Lead Drug In Pediatric Patients With Atopic Dermatitis ↗

September 19, 2023

Arcutis Biotherapeutics Inc (NASDAQ: ARQT) announced that the INTEGUMENT-PED Phase 3 trial of roflumilast cream 0.05%, in children ages 2 to 5 years with mild to moderate atopic dermatitis met its...

Via Benzinga

US Stocks Mostly Higher; RH Posts Upbeat Earnings ↗

September 08, 2023

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 60 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 34,491.98 while the NASDAQ...

Via Benzinga

Topics Stocks

3 Biotech Stocks Due for a Massive Short Squeeze ↗

August 31, 2023

These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 21, 2023

Via Benzinga

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal ↗

August 19, 2023

Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...

Via Talk Markets

Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 21, 2023

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

Via Benzinga

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗

June 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.